|
C1ORF43 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.783200E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.195900E-04 |
| Normal-vs-Stage2 |
1.607550E-02 |
| Normal-vs-Stage3 |
8.810400E-01 |
| Normal-vs-Stage4 |
6.949200E-01 |
| Stage1-vs-Stage2 |
5.283000E-01 |
| Stage1-vs-Stage3 |
7.797500E-03 |
| Stage1-vs-Stage4 |
2.843000E-03 |
| Stage2-vs-Stage3 |
2.759700E-02 |
| Stage2-vs-Stage4 |
1.625900E-02 |
| Stage3-vs-Stage4 |
8.667600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.261900E-03 |
| Normal-vs-AfricanAmerican |
1.583440E-01 |
| Normal-vs-Asian |
7.416400E-01 |
| Caucasian-vs-AfricanAmerican |
1.363180E-03 |
| Caucasian-vs-Asian |
3.986200E-01 |
| AfricanAmerican-vs-Asian |
8.788000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.816100E-02 |
| Normal-vs-Female |
4.324200E-03 |
| Male-vs-Female |
1.713810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.657000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.666170E-01 |
| Normal-vs-Age(61-80Yrs) |
7.261100E-03 |
| Normal-vs-Age(81-100Yrs) |
8.282400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.318600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.625230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.523500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.000600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.438970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.480800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.585800E-04 |
| Normal-vs-Grade 2 |
1.79486999999368E-05 |
| Normal-vs-Grade 3 |
1.328020E-01 |
| Normal-vs-Grade 4 |
8.820400E-04 |
| Grade 1-vs-Grade 2 |
5.478600E-01 |
| Grade 1-vs-Grade 3 |
5.921700E-02 |
| Grade 1-vs-Grade 4 |
3.565500E-04 |
| Grade 2-vs-Grade 3 |
2.705900E-02 |
| Grade 2-vs-Grade 4 |
1.09090003697077E-09 |
| Grade 3-vs-Grade 4 |
6.28389999999257E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62547753035369E-12 |
| Normal-vs-ccB subtype |
4.818500E-04 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.471700E-02 |
| Normal-vs-N1 |
9.636200E-01 |
| N0-vs-N1 |
4.745200E-01 |
|
|
